FDA.reportPublic FDA data

Kimyrsa 1200 MG (as oritavancin diphosphate 1331.16 MG) Injection

RxCUI
2532366
RxNorm name
Kimyrsa 1200 MG (as oritavancin diphosphate 1331.16 MG) Injection
Display name
Kimyrsa 1200 MG (as oritavancin diphosphate 1331.16 MG) Injection
Full name
Kimyrsa 1200 MG (as oritavancin diphosphate 1331.16 MG) Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
KimyrsaORITAVANCIN DIPHOSPHATEMelinta Therapeutics, LLC5e755c40-6e73-4572-b474-4d8a131693d12025-12-18Warnings, Adverse reactionsExact identifier
rxcui: 2532366

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
5e755c40-6e73-4572-b474-4d8a131693d1Kimyrsa 1200 MG Injection [PSN] · oritavancin 1200 MG Injection [Kimyrsa] [SBD] · Kimyrsa 1200 MG (as oritavancin diphosphate 1331.16 MG) Injection [SY] · Kimyrsa 1200 MG Injection [SY]47These highlights do not include all the information needed to use KIMYRSA safely and effectively. See full prescribing information for KIMYRSA. KIMYRSA ® (oritavancin) for injection, for intravenous use Initial U.S. Approval: 201420251218